Maria Grazia Atzori - Concepedia

Author

Maria Grazia Atzori

University of Rome Tor Vergata ORCID

Also Known As

Maria Atzori, Maria Grazia Atzori

Publications

785

Citations

H-Index

Concepts

All Affiliations

University of Rome Tor Vergata Istituto Dermopatico dell'Immacolata Istituti di Ricovero e Cura a Carattere Scientifico National Research Council

About

Maria Grazia Atzori is an author at University of Rome Tor Vergata specializing in medicine, tumor microenvironment, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	211
2	Cell Biology	3	3	178
3	Immunology	2	2	78
4	Pharmacology	2	2	133
5	Health Sciences	1	1	45

Maria Grazia Atzori

Publications

459

Citations

H-Index

Page 1

	Year	Citations
Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth Claudia Ceci, Lucio Tentori, Maria Grazia Atzori, Nutrients Vivo Tumor GrowthUrologyOncologyChemoprevention StrategyGenitourinary Cancer	2016	99
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells Maria Grazia Atzori, Lucio Tentori, Federica Ruffini, Journal of Experimental & Clinical Cancer Research	2017	70
The Anti–Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo Maria Grazia Atzori, Lucio Tentori, Federica Ruffini, Journal of Pharmacology and Experimental Therapeutics	2017	49
Role of VEGFR‐1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib Maria Grazia Atzori, Claudia Ceci, Federica Ruffini, Journal of Cellular and Molecular Medicine	2019	49
Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding Grazia Graziani, Federica Ruffini, Lucio Tentori, Oncotarget Antitumor ActivityImmunologyImmunoeditingLigand BindingImmunotherapy	2016	45
NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug Simona Caporali, Lauretta Levati, Grazia Graziani, Journal of Translational Medicine	2012	37
A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib Grazia Graziani, Simona Artuso, Anastasia De Luca, Biochemical Pharmacology Tumor BiologyMedicineReceptor Tyrosine KinaseMelanomaMelanoma Cells	2015	34
Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma Pedro Miguel Lacal, Maria Grazia Atzori, Federica Ruffini, Pharmacological Research Immune Checkpoint InhibitorsMelanomaImmunologyMonoclonal Antibody D16f7Immune Checkpoint Inhibitor	2020	33
Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1 Federica Ruffini, Lauretta Levati, Grazia Graziani, Oncotarget	2017	22
A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose Diego Sbardella, Grazia Raffaella Tundo, Alice Mecchia, Cell & Bioscience	2022	21

Page 1